EXCiPACT

Activities: Regulatory

Trending Articles

  1. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
  2. Moderna bags $590m US investment to accelerate mRNA-based bird flu vaccine development The pharmaceutical company's investigational influenza vaccine targets the H5 and H7 varieties, and is currently being prepared for Phase III trials
  3. Servier expands AI partnership with Google Cloud to bolster pharma R&D efforts The company will utilise AI and generative AI technology to optimise its therapeutic target/drug discovery and development processes
  4. Kindeva Drug Delivery to supply nerve agent antidote autoinjector to the US SNS The CDMO will produce the DuoDote autoinjecter containing atropine and pralidoxime chloride at its fill/finish manufacturing facility in St Louis, Missouri
  5. Navin Molecular constructs a new R&D facility in Dewas, India The laboratory will enhance the CDMO's small molecule laboratory- and kilo-scale process development capabilities, as well as its analytical development and testing capacity

Upcoming event

Pharma Packaging and Labelling Forum

5–6 March 2025 | Conference | San Diego, US See all

Related Content

Regulatory

Illinois Corn Processing site receives EXCiPACT certification

The certificate demonstrates the site manufactures ethyl alcohol intended for use as a pharmaceutical excipient according to the 2017 EXCiPACT GMP certification standard
Regulatory

JRS Pharma and Gujurat Microwax achieve EXCiPACT certification

EXCiPACT has certified sites in 21 countries to date including the UK, US, Japan and China
Ingredients

Colorcon Westpoint site gains EXCiPACT GMP and GDP Certificate from SGS

Site in Pennsylvania manufactures and distributes lake pigments for use as pharmaceutical excipients
Regulatory

SGS certifies Valtris Speciality Chemical site as GMP

Certification body of EXCiPACT, SGS, has certified that the Cleveland site manufactures metal stearate to GMP standard

EXCiPACT GMP/GDP Certification Scheme

20 March 2019 | Seminar | Frankfurt, Germany
Manufacturing

Qualicaps Romania gains EXCiPACT GMP certification

The certification scope covers the manufacture of gelatin capsule shells for the pharmaceutical and consumer health industries
Regulatory

SGS certifies Dow's Stade site with EXCiPACT GMP standard

The certificate demonstrates that this site manufactures pharmaceutical excipients according to the EXCiPACT Good Manufacturing Practice (GMP) Certification Standard
Subscribe now